BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10821156)

  • 1. An approach to drug abuse, intoxication and withdrawal.
    Giannini AJ
    Am Fam Physician; 2000 May; 61(9):2763-74. PubMed ID: 10821156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug abuse: a biopsychiatric model.
    Giannini AJ; Miller NS
    Am Fam Physician; 1989 Nov; 40(5):173-82. PubMed ID: 2573261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral monoamine neurotransmitters in opioid withdrawal and dependence.
    Ahtee L; Attila LM
    Med Biol; 1987; 65(2-3):113-9. PubMed ID: 2888928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychiatric disorders induced by drug dependence other than alcohol].
    Lejoyeux M; Mourad I; Ades J
    Encephale; 2000; 26(2):21-7. PubMed ID: 10858911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA systems, benzodiazepines, and substance dependence.
    Malcolm RJ
    J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors, neurotransmitters and drug responses.
    Snyder SH
    N Engl J Med; 1979 Mar; 300(9):465-72. PubMed ID: 32488
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of antimyoclonic drugs.
    Pranzatelli MR
    Clin Neurosci; 1995-1996; 3(4):246-52. PubMed ID: 8891398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurobiological basis of drug addiction].
    Fernández-Espejo E
    Rev Neurol; 2002 Apr 1-15; 34(7):659-64. PubMed ID: 12080517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurobiology of alcohol withdrawal inhibitory and excitatory neurotransmitters].
    Eşel E
    Turk Psikiyatri Derg; 2006; 17(2):129-37. PubMed ID: 16755413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of release-modifying drugs.
    Langer SZ
    Handb Exp Pharmacol; 2008; (184):561-73. PubMed ID: 18064425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development to tolerance of and dependence on endogenous neurotransmitters.
    Wyatt RJ; Gillin JC
    Adv Biochem Psychopharmacol; 1975; 13():47-59. PubMed ID: 239533
    [No Abstract]   [Full Text] [Related]  

  • 13. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of the toxic effects of drug abuse and withdrawal symptoms].
    Fossati C
    Clin Ter; 1977 Nov; 83(3):325-33. PubMed ID: 342178
    [No Abstract]   [Full Text] [Related]  

  • 15. New Drugs of Abuse and Withdrawal Syndromes.
    Andrabi S; Greene S; Moukaddam N; Li B
    Emerg Med Clin North Am; 2015 Nov; 33(4):779-95. PubMed ID: 26493523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of drug intoxication: opioids and opiates.
    Goldfrank L; Bresnitz E; Weisman R
    Heart Lung; 1983 Mar; 12(2):114-22. PubMed ID: 6298150
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential adverse effects of discontinuing psychotropic drugs. Part 1: Adrenergic, cholinergic, and histamine drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jun; 48(6):11-4. PubMed ID: 20506969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse.
    Tassin JP
    Biochem Pharmacol; 2008 Jan; 75(1):85-97. PubMed ID: 17686465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.